Invivyd (IVVD) Share-based Compensation Growth (1y) (2021 - 2025)
Invivyd (IVVD) Share-based Compensation Growth (1y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,769.80 Bn | 1,769.74 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 3 | BeOne Medicines | 473.64 Bn | 468.85 Bn | 1.35 Bn | -40.86% |
| 4 | Vertex Pharmaceuticals | 123.74 Bn | 116.49 Bn | 2.59 Bn | 0.18% |
| 5 | Regeneron Pharmaceuticals | 71.73 Bn | 62.97 Bn | 3.31 Bn | 5,886.05% |
| 6 | Belite Bio | 62.10 Bn | 62.10 Bn | - | - |
| 7 | Argenx Se | 54.68 Bn | 49.49 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 38.13 Bn | 35.12 Bn | 959.66 Mn | - |
| 9 | Revolution Medicines | 36.21 Bn | 36.21 Bn | - | - |
| 10 | Invivyd | 102.33 Mn | -124.36 Mn | 16.07 Mn | -16.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -16.13% |
| Sep 30, 2025 | 343.13% |
| Jun 30, 2025 | -62.54% |
| Mar 31, 2025 | 253.23% |
| Dec 31, 2024 | -29.63% |
| Sep 30, 2024 | -32.79% |
| Jun 30, 2024 | 81.51% |
| Mar 31, 2024 | -0.39% |
| Dec 31, 2023 | -78.19% |
| Sep 30, 2023 | -42.37% |
| Jun 30, 2023 | -26.47% |
| Mar 31, 2023 | 212.50% |
| Dec 31, 2022 | 301.05% |
| Sep 30, 2022 | 23.75% |
| Jun 30, 2022 | 90.34% |
| Mar 31, 2022 | 194.38% |
| Dec 31, 2021 | -10,008.00% |